{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:03:01Z","timestamp":1782601381511,"version":"3.54.5"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ejim.2015.09.022","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T04:00:59Z","timestamp":1445572859000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"C","title":["IgG4-related disease: A relatively new concept for clinicians"],"prefix":"10.1016","volume":"27","author":[{"given":"Lilian","family":"Vasaitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejim.2015.09.022_bb0005","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":"A new clinicopathological entity of IgG4-related autoimmune disease","volume":"38","author":"Kamisawa","year":"2003","journal-title":"J Gastroenterol"},{"issue":"8","key":"10.1016\/j.ejim.2015.09.022_bb0010","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2008.089169","article-title":"Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders","volume":"68","author":"Masaki","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ejim.2015.09.022_bb0015","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gut.2008.172908","article-title":"Standard steroid treatment for autoimmune pancreatitis","volume":"58","author":"Kamisawa","year":"2009","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.ejim.2015.09.022_bb0020","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","article-title":"Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ejim.2015.09.022_bb0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/all.12320","article-title":"Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease","volume":"69","author":"Della Torre","year":"2014","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.ejim.2015.09.022_bb0030","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/03009742.2013.822094","article-title":"IgG4-related disease in a Chinese cohort: a prospective study","volume":"43","author":"Chen","year":"2014","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.ejim.2015.09.022_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/BOR.0b013e3283412fd4","article-title":"What is IgG4? A review of the biology of a unique immunoglobulin subtype","volume":"23","author":"Nirula","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.ejim.2015.09.022_bb0040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/art.33320","article-title":"Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease","volume":"64","author":"Tanaka","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.ejim.2015.09.022_bb0045","doi-asserted-by":"crossref","first-page":"R171","DOI":"10.1186\/ar3924","article-title":"Analysis of IgG4 class switch-related molecules in IgG4-related disease","volume":"14","author":"Tsuboi","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.ejim.2015.09.022_bb0050","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/modpathol.2013.236","article-title":"T helper 2 and regulatory T-cell cytokine production by mast cells: a key factor in the pathogenesis of IgG4-related disease","volume":"27","author":"Takeuchi","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejim.2015.09.022_bb0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.0105-2896.2006.00415.x","article-title":"The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells","volume":"212","author":"Shevach","year":"2006","journal-title":"Immunol Rev"},{"issue":"11","key":"10.1016\/j.ejim.2015.09.022_bb0060","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1398-9995.2008.01774.x","article-title":"Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors","volume":"63","author":"Meiler","year":"2008","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.ejim.2015.09.022_bb0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2220\/biomedres.36.143","article-title":"CD14+ follicular dendritic cells in lymphoid follicles may play a role in the pathogenesis of IgG4-related disease","volume":"36","author":"Satoh-Nakamura","year":"2015","journal-title":"Biomed Res"},{"issue":"6","key":"10.1016\/j.ejim.2015.09.022_bb0070","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood.V99.6.2154","article-title":"The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression","volume":"99","author":"Medina","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejim.2015.09.022_bb0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ejim.2015.09.022_bb0080","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","article-title":"De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease","volume":"134","author":"Mattoo","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.ejim.2015.09.022_bb0085","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.27435","article-title":"Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease","volume":"62","author":"Khosroshahi","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ejim.2015.09.022_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","article-title":"Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients","volume":"91","author":"Khosroshahi","year":"2012","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.ejim.2015.09.022_bb0095","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/all.12342","article-title":"Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy","volume":"69","author":"Mattoo","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.ejim.2015.09.022_bb0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaut.2013.07.007","article-title":"T helper subsets in Sjogren's syndrome and IgG4-related dacryoadenitis and sialoadenitis: a critical review","volume":"51","author":"Moriyama","year":"2014","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.ejim.2015.09.022_bb0105","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bbadis.2012.12.007","article-title":"Strategies for anti-fibrotic therapies","volume":"1832","author":"Rosenbloom","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"16","key":"10.1016\/j.ejim.2015.09.022_bb0110","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ejim.2015.09.022_bb0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: an odd antibody","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"5844","key":"10.1016\/j.ejim.2015.09.022_bb0120","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ejim.2015.09.022_bb0125","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4049\/jimmunol.130.2.722","article-title":"Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response","volume":"130","author":"Aalberse","year":"1983","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ejim.2015.09.022_bb0130","first-page":"471","article-title":"A clinicopathologic study of Mikulicz's disease","volume":"29","author":"Morgan","year":"1953","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.ejim.2015.09.022_bb0135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/rheumatology\/keh447","article-title":"Clinical and pathological differences between Mikulicz's disease and Sjogren's syndrome","volume":"44","author":"Yamamoto","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejim.2015.09.022_bb0140","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/BF02232341","article-title":"Chronic inflammatory sclerosis of the pancreas\u2014an autonomous pancreatic disease?","volume":"6","author":"Sarles","year":"1961","journal-title":"Am J Dig Dis"},{"issue":"7","key":"10.1016\/j.ejim.2015.09.022_bb0145","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/BF02285209","article-title":"Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis","volume":"40","author":"Yoshida","year":"1995","journal-title":"Dig Dis Sci"},{"issue":"10","key":"10.1016\/j.ejim.2015.09.022_bb0150","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"issue":"9315","key":"10.1016\/j.ejim.2015.09.022_bb0155","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(02)08359-9","article-title":"Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis","volume":"359","author":"Hamano","year":"2002","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ejim.2015.09.022_bb0160","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1111\/j.1572-0241.2003.08758.x","article-title":"Autoimmune pancreatitis is a systemic autoimmune disease","volume":"98","author":"Kamisawa","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.ejim.2015.09.022_bb0165","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.34593","article-title":"Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.ejim.2015.09.022_bb0170","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.ejim.2015.09.022_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/s10165-011-0508-6","article-title":"A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol\/Jpn Rheum Assoc"},{"key":"10.1016\/j.ejim.2015.09.022_bb0180","first-page":"358371","article-title":"Prevalence of IgG4-related disease in Japan based on nationwide survey in 2009","author":"Uchida","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.ejim.2015.09.022_bb0185","first-page":"1","article-title":"Everyday clinical practice in IgG4-related dacryoadenitis and\/or sialadenitis: results from the SMART database","author":"Yamamoto","year":"2014","journal-title":"Mod Rheumatol\/Jpn Rheum Assoc"},{"key":"10.1016\/j.ejim.2015.09.022_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: clinical and laboratory features in 125 patients","author":"Wallace","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.ejim.2015.09.022_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1546-0096-9-1","article-title":"Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature","volume":"9","author":"Mannion","year":"2011","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"10.1016\/j.ejim.2015.09.022_bb0200","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00428-013-1480-7","article-title":"Idiopathic vs. secondary retroperitoneal fibrosis: a clinicopathological study of 12 cases, with emphasis to possible relationship to IgG4-related disease","volume":"463","author":"Laco","year":"2013","journal-title":"Virchows Arch Int J Pathol"},{"issue":"2","key":"10.1016\/j.ejim.2015.09.022_bb0205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/01676830.2013.764449","article-title":"IgG4 orbital inflammation in a 5-year-old child presenting as an orbital mass","volume":"32","author":"Kalapesi","year":"2013","journal-title":"Orbit"},{"issue":"1","key":"10.1016\/j.ejim.2015.09.022_bb0210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol\/Jpn Rheum Assoc"},{"issue":"5","key":"10.1016\/j.ejim.2015.09.022_bb0215","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10157-011-0521-2","article-title":"Proposal for diagnostic criteria for IgG4-related kidney disease","volume":"15","author":"Kawano","year":"2011","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"10.1016\/j.ejim.2015.09.022_bb0220","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","article-title":"International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology","volume":"40","author":"Shimosegawa","year":"2011","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.ejim.2015.09.022_bb0225","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nrrheum.2013.183","article-title":"Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist","volume":"10","author":"Yamamoto","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"10.1016\/j.ejim.2015.09.022_bb0230","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/PAS.0b013e31816148ad","article-title":"Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease","volume":"32","author":"Cheuk","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ejim.2015.09.022_bb0235","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s10384-011-0003-9","article-title":"Multifocal mucosa-associated lymphoid tissue lymphoma associated with IgG4-related disease: a case report","volume":"55","author":"Oyama","year":"2011","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ejim.2015.09.022_bb0240","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/modpathol.2010.206","article-title":"Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases","volume":"24","author":"Venkataraman","year":"2011","journal-title":"Mod Pathol"},{"issue":"1\u20132","key":"10.1016\/j.ejim.2015.09.022_bb0245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaut.2012.01.007","article-title":"The immunobiology and clinical characteristics of IgG4 related diseases","volume":"39","author":"Takahashi","year":"2012","journal-title":"J Autoimmun"},{"issue":"129","key":"10.1016\/j.ejim.2015.09.022_bb0250","article-title":"Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease","volume":"16","author":"Kiyama","year":"2015","journal-title":"BMC musculoskeletal disorders"},{"key":"10.1016\/j.ejim.2015.09.022_bb0255","first-page":"580814","article-title":"Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease","author":"Masaki","year":"2012","journal-title":"Int J Rheumatol"},{"issue":"1","key":"10.1016\/j.ejim.2015.09.022_bb0260","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","article-title":"The diagnostic utility of serum IgG4 concentrations in IgG4-related disease","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ejim.2015.09.022_bb0265","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/modpathol.2013.159","article-title":"IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease","volume":"27","author":"Geyer","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejim.2015.09.022_bb0270","first-page":"602809","article-title":"Pathologies associated with serum IgG4 elevation","author":"Ebbo","year":"2012","journal-title":"Int J Rheumatol"},{"issue":"4","key":"10.1016\/j.ejim.2015.09.022_bb0275","doi-asserted-by":"crossref","first-page":"e0124233","DOI":"10.1371\/journal.pone.0124233","article-title":"Detection of serum IgG4 levels in patients with IgG4-related disease and other disorders","volume":"10","author":"Su","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejim.2015.09.022_bb0280","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/art.38193","article-title":"Brief report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease","volume":"66","author":"Khosroshahi","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.ejim.2015.09.022_bb0285","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.cgh.2009.04.020","article-title":"A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer","volume":"7","author":"Chari","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.ejim.2015.09.022_bb0290","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1148\/radiol.2423060003","article-title":"Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings","volume":"242","author":"Takahashi","year":"2007","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejim.2015.09.022_bb0295","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1148\/radiol.2511080965","article-title":"Immunoglobulin G4-related lung disease: CT findings with pathologic correlations","volume":"251","author":"Inoue","year":"2009","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.ejim.2015.09.022_bb0300","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/radiol.11102250","article-title":"Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients","volume":"261","author":"Inoue","year":"2011","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.ejim.2015.09.022_bb0305","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00234-012-1012-1","article-title":"Radiological features of IgG4-related disease in the head, neck, and brain","volume":"54","author":"Katsura","year":"2012","journal-title":"Neuroradiology"},{"issue":"4","key":"10.1016\/j.ejim.2015.09.022_bb0310","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.crad.2011.10.011","article-title":"Utility of FDG PET\/CT in IgG4-related systemic disease","volume":"67","author":"Nakatani","year":"2012","journal-title":"Clin Radiol"},{"issue":"1","key":"10.1016\/j.ejim.2015.09.022_bb0315","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/acr.22058","article-title":"Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography\/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study","volume":"66","author":"Ebbo","year":"2014","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.ejim.2015.09.022_bb0320","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/rheumatology\/kes358","article-title":"Necessity of early intervention for IgG4-related disease\u2014delayed treatment induces fibrosis progression","volume":"52","author":"Shimizu","year":"2013","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.ejim.2015.09.022_bb0325","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/jcp.21.5.656","article-title":"Labial salivary gland biopsy in Sjogren's disease","volume":"21","author":"Chisholm","year":"1968","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.ejim.2015.09.022_bb0330","first-page":"2673","article-title":"Usefulness of minor salivary gland biopsy in the diagnosis of IgG4-related disease: a case report","volume":"7","author":"Doe","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"10.1016\/j.ejim.2015.09.022_bb0335","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ijom.2014.06.014","article-title":"The diagnostic utility of biopsies from the submandibular and labial salivary glands in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease","volume":"43","author":"Moriyama","year":"2014","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"12","key":"10.1016\/j.ejim.2015.09.022_bb0340","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.autrev.2014.08.013","article-title":"The clinical spectrum of IgG4-related disease","volume":"13","author":"Brito-Zeron","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.ejim.2015.09.022_bb0345","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MD.0b013e3182433d77","article-title":"IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry","volume":"91","author":"Ebbo","year":"2012","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.ejim.2015.09.022_bb0350","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","article-title":"IgG4-related disease: a cross-sectional study of 114 cases","volume":"34","author":"Zen","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejim.2015.09.022_bb0355","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-pathol-012513-104708","article-title":"IgG4-related disease","volume":"9","author":"Mahajan","year":"2014","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"10.1016\/j.ejim.2015.09.022_bb0360","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/modpathol.2009.17","article-title":"Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease","volume":"22","author":"Sato","year":"2009","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.ejim.2015.09.022_bb0365","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.semarthrit.2013.11.008","article-title":"Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review","volume":"43","author":"Wallace","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"44","key":"10.1016\/j.ejim.2015.09.022_bb0370","doi-asserted-by":"crossref","first-page":"16559","DOI":"10.3748\/wjg.v20.i44.16559","article-title":"Diagnosis of autoimmune pancreatitis","volume":"20","author":"Matsubayashi","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ejim.2015.09.022_bb0375","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00535-011-0465-z","article-title":"Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification","volume":"47","author":"Nakazawa","year":"2012","journal-title":"J Gastroenterol"},{"issue":"9","key":"10.1016\/j.ejim.2015.09.022_bb0380","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1007\/s11605-014-2568-3","article-title":"IgG4-related cholecystitis presenting as biliary malignancy: report of three cases","volume":"18","author":"Feely","year":"2014","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ejim.2015.09.022_bb0385","first-page":"198314","article-title":"The utility of serum IgG4 concentrations as a biomarker","author":"Kawa","year":"2012","journal-title":"Int J Rheumatol"},{"issue":"4","key":"10.1016\/j.ejim.2015.09.022_bb0390","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.rdc.2007.07.013","article-title":"Retroperitoneal fibrosis: evolving concepts","volume":"33","author":"Vaglio","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.ejim.2015.09.022_bb0395","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ki.2013.393","article-title":"IgG4-related kidney disease","volume":"85","author":"Saeki","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2015.09.022_bb0400","first-page":"139409","article-title":"IgG4-related disease is not associated with antibody to the phospholipase A2 receptor","author":"Khosroshahi","year":"2012","journal-title":"Int J Rheumatol"},{"issue":"10","key":"10.1016\/j.ejim.2015.09.022_bb0405","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ki.2010.271","article-title":"Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis","volume":"78","author":"Saeki","year":"2010","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.ejim.2015.09.022_bb0410","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/ndt\/gfr761","article-title":"Light-microscopic characteristics of IgG4-related tubulointerstitial nephritis: distinction from non-IgG4-related tubulointerstitial nephritis","volume":"27","author":"Yoshita","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.ejim.2015.09.022_bb0415","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ki.2012.382","article-title":"Membranous glomerulonephritis is a manifestation of IgG4-related disease","volume":"83","author":"Alexander","year":"2013","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ejim.2015.09.022_bb0420","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ki.2013.191","article-title":"The clinical course of patients with IgG4-related kidney disease","volume":"84","author":"Saeki","year":"2013","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.ejim.2015.09.022_bb0425","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/j.ijcard.2007.06.111","article-title":"Constrictive pericarditis as an emerging manifestation of hyper-IgG4 disease","volume":"130","author":"Sugimoto","year":"2008","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.ejim.2015.09.022_bb0430","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.athoracsur.2012.11.057","article-title":"Immunoglobulin G4-related disease of the heart causing aortic regurgitation and heart block","volume":"95","author":"Yamauchi","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.ejim.2015.09.022_bb0435","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.humpath.2007.10.023","article-title":"A case of multiple immunoglobulin G4-related periarteritis: a tumorous lesion of the coronary artery and abdominal aortic aneurysm","volume":"39","author":"Matsumoto","year":"2008","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.ejim.2015.09.022_bb0440","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.humpath.2011.09.019","article-title":"Immunoglobulin G4-related coronary periarteritis in a patient presenting with myocardial ischemia","volume":"43","author":"Tanigawa","year":"2012","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.ejim.2015.09.022_bb0445","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.carpath.2013.05.003","article-title":"Sudden coronary death due to IgG4-related disease","volume":"22","author":"Gutierrez","year":"2013","journal-title":"Cardiovasc Pathol Off J Soc Cardiovasc Pathol"},{"issue":"6","key":"10.1016\/j.ejim.2015.09.022_bb0450","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jvs.2010.06.072","article-title":"A clinicopathologic study of immunoglobulin G4-related sclerosing disease of the thoracic aorta","volume":"52","author":"Kasashima","year":"2010","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.ejim.2015.09.022_bb0455","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/PAS.0b013e3181342f0d","article-title":"Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis","volume":"32","author":"Kasashima","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.ejim.2015.09.022_bb0460","first-page":"1713","article-title":"Inflammatory thoracic aortic aneurysm (lymphoplasmacytic thoracic aortitis): a 13-year-experience at a German Heart Center with emphasis on possible role of IgG4","volume":"6","author":"Agaimy","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"10.1016\/j.ejim.2015.09.022_bb0465","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1053\/j.semdp.2012.07.003","article-title":"Retroperitoneal and aortic manifestations of immunoglobulin G4-related disease","volume":"29","author":"Zen","year":"2012","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"10.1016\/j.ejim.2015.09.022_bb0470","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/ar4671","article-title":"Clinical course after corticosteroid therapy in IgG4-related aortitis\/periaortitis and periarteritis: a retrospective multicenter study","volume":"16","author":"Mizushima","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.ejim.2015.09.022_bb0475","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/jclinpath-2011-200485","article-title":"Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease","volume":"65","author":"Deshpande","year":"2012","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1016\/j.ejim.2015.09.022_bb0480","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jamaneurol.2014.243","article-title":"IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment","volume":"71","author":"Lu","year":"2014","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.ejim.2015.09.022_bb0485","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamaneurol.2014.40","article-title":"Central nervous system manifestation of IgG4-related disease","volume":"71","author":"Regev","year":"2014","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.ejim.2015.09.022_bb0490","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1440-1827.2012.02805.x","article-title":"IgG4-related sclerosing mesenteritis: a rare mesenteric disease of unknown etiology","volume":"62","author":"Minato","year":"2012","journal-title":"Pathol Int"},{"issue":"5","key":"10.1016\/j.ejim.2015.09.022_bb0495","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bjd.13296","article-title":"IgG4-related skin disease","volume":"171","author":"Tokura","year":"2014","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.ejim.2015.09.022_bb0500","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/rheumatology\/ker350","article-title":"Arthropathy with infiltrate IgG4-positive plasma cells in synovium","volume":"51","author":"Umekita","year":"2012","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.ejim.2015.09.022_bb0505","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.ejim.2015.09.022_bb0515","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3960\/jslrt.54.95","article-title":"IgG4-related disease: diagnostic methods and therapeutic strategies in Japan","volume":"54","author":"Masaki","year":"2014","journal-title":"J Clin Exp Hematopath"},{"issue":"3","key":"10.1016\/j.ejim.2015.09.022_bb0520","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.ejim.2015.09.022_bb0525","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/gut.2009.183293","article-title":"Corticosteroid treatment for autoimmune pancreatitis","volume":"58","author":"Pannala","year":"2009","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ejim.2015.09.022_bb0530","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/jamaneurol.2013.3950","article-title":"Steroid-resistant relapsing IgG4-related pachymeningitis treated with methotrexate","volume":"71","author":"Hyun","year":"2014","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.ejim.2015.09.022_bb0535","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ckj\/sfs180","article-title":"Membranous nephropathy with repeated flares in IgG4-related disease","volume":"6","author":"Kanda","year":"2013","journal-title":"Clin Kidney J"},{"issue":"8","key":"10.1016\/j.ejim.2015.09.022_bb0540","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1440-1827.2008.02257.x","article-title":"Ocular adnexal IgG4-related disease has uniform clinicopathology","volume":"58","author":"Sato","year":"2008","journal-title":"Pathol Int"},{"issue":"6","key":"10.1016\/j.ejim.2015.09.022_bb0545","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ejim.2015.09.022_bb0550","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/TP.0b013e3182911739","article-title":"Proteasome inhibition profoundly affects activated human B cells","volume":"95","author":"Mulder","year":"2013","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ejim.2015.09.022_bb0555","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3816\/CLML.2010.n.034","article-title":"Treatment with bortezomib of a patient having hyper IgG4 disease","volume":"10","author":"Khan","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1\u20133","key":"10.1016\/j.ejim.2015.09.022_bb0560","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2005.08.045","article-title":"Inhibitory effects of histamine H4 receptor antagonists on experimental colitis in the rat","volume":"522","author":"Varga","year":"2005","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.ejim.2015.09.022_bb0565","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1023\/A:1012437607881","article-title":"Mechanisms of tamoxifen-induced apoptosis","volume":"6","author":"Mandlekar","year":"2001","journal-title":"Apoptosis"},{"issue":"5","key":"10.1016\/j.ejim.2015.09.022_bb0570","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ejim.2012.11.010","article-title":"Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis","volume":"24","author":"van Bommel","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2015.09.022_bb0575","first-page":"259408","article-title":"Development of an IgG4-RD responder index","author":"Carruthers","year":"2012","journal-title":"Int J Rheumatol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515003295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515003295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:21:22Z","timestamp":1692112882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620515003295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":114,"alternative-id":["S0953620515003295"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2015.09.022","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgG4-related disease: A relatively new concept for clinicians","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2015.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}